Coding Guidelines

Inclusion Terms

  • Primary hypercoagulable states

Excludes1 (Mutually Exclusive)

These codes should never be used together with D68.5

  • D68.61 - antiphospholipid syndrome (D68.61)
  • D68.62 - lupus anticoagulant (D68.62)
  • D68.69 - secondary activated protein C resistance (D68.69)
  • D68.69 - secondary antiphospholipid antibody syndrome (D68.69)
  • D68.69 - secondary lupus anticoagulant with hypercoagulable state (D68.69)
  • D68.69 - secondary systemic lupus erythematosus [SLE] inhibitor with hypercoagulable state (D68.69)
  • R76.0 - systemic lupus erythematosus [SLE] inhibitor finding without diagnosis (R76.0)
  • D68.312 - systemic lupus erythematosus [SLE] inhibitor with hemorrhagic disorder (D68.312)
  • M31.19 - thrombotic thrombocytopenic purpura (M31.19)

Get started with Scope today

Spend more time caring for patients, not charting. Scope captures your patient encounters in real time and quickly generates high-quality clinical notes – and it's completely free.

AnneLisaDavid
1k+

from 1k+ happy clinicians

Get started now